Logo image of BFRG

BULLFROG AI HOLDINGS INC (BFRG) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:BFRG - US12021E1091 - Common Stock

1.15 USD
+0.02 (+1.77%)
Last: 12/8/2025, 3:59:51 PM

BFRG Key Statistics, Chart & Performance

Key Statistics
Market Cap13.12M
Revenue(TTM)113.30K
Net Income(TTM)-6.76M
Shares11.41M
Float8.31M
52 Week High4.84
52 Week Low0.8
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.7
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2023-02-14
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology


BFRG short term performance overview.The bars show the price performance of BFRG in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20

BFRG long term performance overview.The bars show the price performance of BFRG in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of BFRG is 1.15 USD. In the past month the price increased by 17.7%. In the past year, price decreased by -57.99%.

BULLFROG AI HOLDINGS INC / BFRG Daily stock chart

BFRG Latest News, Press Relases and Analysis

BFRG Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 30.89 39.30B
DOCS DOXIMITY INC-CLASS A 27.85 8.60B
WAY WAYSTAR HOLDING CORP 24.78 6.35B
HTFL HEARTFLOW INC N/A 2.38B
CERT CERTARA INC 18.18 1.45B
TDOC TELADOC HEALTH INC N/A 1.34B
SDGR SCHRODINGER INC N/A 1.31B
PHR PHREESIA INC N/A 1.21B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.11B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP 633.5 1.07B
GDRX GOODRX HOLDINGS INC-CLASS A 7.77 923.25M
HSTM HEALTHSTREAM INC 35.37 713.56M

About BFRG

Company Profile

BFRG logo image BullFrog AI Holdings, Inc. is a digital biopharmaceutical company, which engages in artificial intelligence and machine learning driven analysis of complex data sets in medicine and healthcare. The company is headquartered in Gaithersburg, Maryland and currently employs 9 full-time employees. The company went IPO on 2023-02-14. The firm is focused specifically on advanced artificial intelligence/machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

Company Info

BULLFROG AI HOLDINGS INC

325 Ellington Blvd, Unit 317

Gaithersburg MARYLAND US

Employees: 6

BFRG Company Website

BFRG Investor Relations

Phone: 12406586710

BULLFROG AI HOLDINGS INC / BFRG FAQ

Can you describe the business of BULLFROG AI HOLDINGS INC?

BullFrog AI Holdings, Inc. is a digital biopharmaceutical company, which engages in artificial intelligence and machine learning driven analysis of complex data sets in medicine and healthcare. The company is headquartered in Gaithersburg, Maryland and currently employs 9 full-time employees. The company went IPO on 2023-02-14. The firm is focused specifically on advanced artificial intelligence/machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.


What is the current price of BFRG stock?

The current stock price of BFRG is 1.15 USD. The price increased by 1.77% in the last trading session.


Does BULLFROG AI HOLDINGS INC pay dividends?

BFRG does not pay a dividend.


How is the ChartMill rating for BULLFROG AI HOLDINGS INC?

BFRG has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the PE ratio for BFRG stock?

BULLFROG AI HOLDINGS INC (BFRG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.7).


Would investing in BULLFROG AI HOLDINGS INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BFRG.


BFRG Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to BFRG. When comparing the yearly performance of all stocks, BFRG is a bad performer in the overall market: 89.58% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BFRG Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to BFRG. While BFRG seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BFRG Financial Highlights

Over the last trailing twelve months BFRG reported a non-GAAP Earnings per Share(EPS) of -0.7. The EPS increased by 18.62% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -250.37%
ROE -348.45%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%31.82%
Sales Q2Q%N/A
EPS 1Y (TTM)18.62%
Revenue 1Y (TTM)-100%

BFRG Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

BFRG Ownership

Ownership
Inst Owners3.61%
Ins Owners20.91%
Short Float %3.95%
Short Ratio1.23